Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Omega-3-Acid Ethyl Esters. Always confirm against the full prescribing information.
48 interactions
Acenocoumarol
The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Acenocoumarol.
Level 2 evidence
Acetylsalicylic acid
The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Acetylsalicylic acid.
Level 2 evidence
Alteplase
The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Alteplase.
Level 2 evidence
Anagrelide
The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Anagrelide.
Level 2 evidence
Antithrombin Alfa
The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Antithrombin Alfa.
Level 2 evidence
Antithrombin III human
The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Antithrombin III human.
Level 2 evidence
Apixaban
The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Apixaban.
Level 2 evidence
Argatroban
The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Argatroban.
Level 2 evidence
Astaxanthin
The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Astaxanthin.
Level 2 evidence
Betrixaban
The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Betrixaban.
Level 2 evidence
Bivalirudin
The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Bivalirudin.
Level 2 evidence
Brinase
The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Brinase.
Omega-3-Acid Ethyl Esters has 48 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Omega-3-Acid Ethyl Esters has 0 major, 0 moderate, and 48 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Omega-3-Acid Ethyl Esters. Always confirm against the full prescribing information.